Table 3.
Treatment characteristics.
| Treatment | mEHT | Control | p-Value | |||
|---|---|---|---|---|---|---|
| Characteristics | 106 | (50.5%) | 104 | (49.5%) | ||
| No of HDR BT doses | 0 | 0 | (0.0%) | 0 | (0.0%) | p = 0.223 |
| 1 | 0 | (0.0%) | 2 | (2.0%) | ||
| 2 | 3 | (2.9%) | 1 | (1.0%) | ||
| 3 | 101 | (97.1%) | 99 | (97.1%) | ||
| No of Cisplatin Doses | 0 | 14 | (13.6%) | 11 | (10.7%) | p = 0.727 |
| 1 | 42 | (40.8%) | 47 | (45.6%) | ||
| 2 | 47 | (45.6%) | 45 | (43.7%) | ||
| Total RT Dose | Median | 74 | 74 | p = 0.6133 | ||
| Min | 20 | 2 | ||||
| Max | 74 | 74 | ||||
| Days between enrolment and Treatment | Median | 37 | 37 | p = 0.2241 | ||
| Min | 18 | 21 | ||||
| Max | 79 | 104 | ||||
| No of mEHT doses | Median | 10 | ||||
| Min | 1 | |||||
| Max | 10 | |||||
Abbreviations: HDR BT: High Dose Rate Brachytherapy; mEHT: Modulated Electro-Hyperthermia; RT: Radiotherapy.